STAT+: David Sackler acknowledges ‘moral responsibility’ to address opioid crisis, but refuses to pay settlement without immunity
Amid a contentious bankruptcy court trial, a member of the Sackler family that owns Purdue Pharma said they would not proceed with plans to contribute more than $4.3 billion to settle massive litigation over the opioid crisis unless they are granted immunity from all existing and future legal claims.
David Sackler, 41, who is a Purdue board member and grandson one of the founders of the drug maker, acknowledged the family has a “moral responsibility to try and help, and that’s what this settlement is designed to do.” But he also maintained that without receiving a global release from legal liability, the carefully crafted settlement would fall apart.